Cargando…
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
Autores principales: | Ji, Jingjing, Zhang, Jinxia, Shao, Ziyun, Xie, Qifeng, Zhong, Li, Liu, Zhifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503440/ https://www.ncbi.nlm.nih.gov/pubmed/32958060 http://dx.doi.org/10.1186/s13054-020-03287-6 |
Ejemplares similares
-
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020) -
Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Jung, Jiwon, et al.
Publicado: (2020) -
Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study
por: Ji, Jingjing, et al.
Publicado: (2021) -
Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis
por: Li, Jianbo, et al.
Publicado: (2021) -
Risk factors for the delayed viral clearance in COVID‐19 patients
por: Chen, Xiaoping, et al.
Publicado: (2021)